Cargando…
JMJD2C triggers the growth of multiple myeloma cells via activation of β-catenin
Emerging evidence has indicated that histone modification and its related regulators are involved in the progression of multiple myeloma (MM) cells. In the present study, the expression of Jumonji C domain-containing 2 (JMJD2) was examined in both MM tissues and healthy controls. The roles of JMJD2C...
Autores principales: | Lv, Ming, Liu, Qicai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860002/ https://www.ncbi.nlm.nih.gov/pubmed/33469678 http://dx.doi.org/10.3892/or.2021.7934 |
Ejemplares similares
-
JMJD2C promotes colorectal cancer metastasis via regulating histone methylation of MALAT1 promoter and enhancing β-catenin signaling pathway
por: Wu, Xinnan, et al.
Publicado: (2019) -
Correction: JMJD2C promotes colorectal cancer metastasis via regulating histone methylation of MALAT1 promoter and enhancing β-catenin signaling pathway
por: Wu, Xinnan, et al.
Publicado: (2022) -
The Novel Protease Activities of JMJD5–JMJD6–JMJD7 and Arginine Methylation Activities of Arginine Methyltransferases Are Likely Coupled
por: Liu, Haolin, et al.
Publicado: (2022) -
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML
por: Yu, Shan-He, et al.
Publicado: (2018) -
Silencing RRM2 inhibits multiple myeloma by targeting the Wnt/β-catenin signaling pathway
por: Liu, Xia, et al.
Publicado: (2019)